Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dr Agarwal'S Eye HospitalBOM:526783 +1.52%95 Return-on-Tangible-Asset is 8.79% as of Mar. 2026, which is 16% below its 10-year median of 10.41. GuruFocus rates BOM:526783 with a GF Score™ of 95/100 and a GF Value™ of ₹5,419.14 (Fairly Valued). The stock has 3 warning signs investors should review. Among 679 Healthcare Providers & Services companies, Dr Agarwal'S Eye Hospital ranks better than 81.44% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Dr Agarwal'S Eye Hospital's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹650 Mil. Dr Agarwal'S Eye Hospital's average total tangible assets for the quarter that ended in Mar. 2026 was ₹7,387 Mil. Therefore, Dr Agarwal'S Eye Hospital's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 8.79%.
The historical rank and industry rank for Dr Agarwal'S Eye Hospital's Return-on-Tangible-Asset or its related term are showing as below:
BOM:526783'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -1.12 Med: 10.41 Max: 13.68
Current: 10.39
During the past 13 years, Dr Agarwal'S Eye Hospital's highest Return-on-Tangible-Asset was 13.68%. The lowest was -1.12%. And the median was 10.41%.
BOM:526783's Return-on-Tangible-Asset is ranked better than 81.44% of 679
companies
in the Healthcare Providers & Services industry
Industry Median: 2.51
vs BOM:526783: 10.39
Dr Agarwal'S Eye Hospital (BOM:526783) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Dr Agarwal'S Eye Hospital Return-on-Tangible-Asset Related Terms
Dr Agarwal'S Eye Hospital Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Dr Agarwal'S Eye Hospital's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Agarwal'S Eye Hospital Return-on-Tangible-Asset Chart
BOM:526783 vs HCA, THC, DVA: Return-on-Tangible-Asset Comparison
For the Medical Care Facilities subindustry, Dr Agarwal'S Eye Hospital's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Agarwal'S Eye Hospital Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dr Agarwal'S Eye Hospital's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Dr Agarwal'S Eye Hospital's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 8.79% mean?
Dr Agarwal'S Eye Hospital (BOM:526783) has a Return-on-Tangible-Asset of 8.79% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Dr Agarwal'S Eye Hospital and its competitors. This is 16% below median its historical median of 10.41. According to the industry distribution chart, Dr Agarwal'S Eye Hospital ranks #126 out of 679 companies in the Healthcare Providers & Services industry, placing it in the top 18.6%.
Is Dr Agarwal'S Eye Hospital's Return-on-Tangible-Asset too high?
Dr Agarwal'S Eye Hospital's current Return-on-Tangible-Asset of 8.79% is 16% below median its 10-year median of 10.41. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.51. Dr Agarwal'S Eye Hospital's value of 8.79% is 250.2% above this industry median. Based on the distribution chart, Dr Agarwal'S Eye Hospital ranks #126 out of 679 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Dr Agarwal'S Eye Hospital has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr Agarwal'S Eye Hospital's Return-on-Tangible-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dr Agarwal'S Eye Hospital ranks #126 out of 679 companies for Return-on-Tangible-Asset. This places Dr Agarwal'S Eye Hospital in the top 19% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 2.51. Dr Agarwal'S Eye Hospital's value of 8.79% is 250.2% above this benchmark. While the company's 10-year median is 10.41 vs. the industry median of 2.51, Dr Agarwal'S Eye Hospital has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.51, based on 679 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Agarwal'S Eye Hospital's current Return-on-Tangible-Asset of 8.79% is 250.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Dr Agarwal'S Eye Hospital and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Agarwal'S Eye Hospital's current Return-on-Tangible-Asset is 8.79%, which is 16% below median its own 10-year median of 10.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Agarwal'S Eye Hospital stock overvalued right now?
Based on GuruFocus' analysis, Dr Agarwal'S Eye Hospital (BOM:526783) is currently considered Fairly Valued. The stock's GF Value™ is ₹5,419.14, compared to a current price of ₹5,085.85 — trading 6.2% below its estimated fair value. The current Return-on-Tangible-Asset is 8.79%, which is 16% below median its 10-year median of 10.41 and 250.2% above the Healthcare Providers & Services industry median of 2.51. Dr Agarwal'S Eye Hospital's overall GF Score™ is 95/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Dr Agarwal'S Eye Hospital (BOM:526783), the current Return-on-Tangible-Asset is 8.79% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr Agarwal'S Eye Hospital (BOM:526783) Overvalued in 2026?
Based on GuruFocus' analysis, Dr Agarwal'S Eye Hospital stock appears to be undervalued.
The current stock price of ₹5,085.85 is trading 6.2% below its estimated GF Value™ of ₹5,419.14.
GuruFocus considers Dr Agarwal'S Eye Hospital to be Fairly Valued.
Key valuation signals for BOM:526783:
Return-on-Tangible-Asset: 8.79% (16% below median its 10-year median of 10.41)
GF Value™: ₹5,419.14 vs. price of ₹5,085.85 (6.2% below fair value)
Industry Position: 250.2% above the Healthcare Providers & Services median (#126 of 679)
No single metric tells the full story. See the BOM:526783 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr Agarwal'S Eye Hospital Ltd is a provider of eye care and related services. The company is predominantly engaged in running, owning and managing eye care hospitals, opticals, pharmacies, and related services. It operates across various locations in India and provides solutions like Refractive Surgery, Lasik Surgery, Oculoplasty, Laser Cataract Surgery, and SMILE Eye Surgery among others.
95GF Score
Get the complete analysis for BOM:526783
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:526783 has been successfully added to your 
